SEC Charges Stryker Corporation With Violating FCPA

Medical device company Stryker Corporation has agreed to pay more than $13.2 million to the Securities and Exchange Commission to settle civil charges for violating the Foreign Corrupt Practices Act.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.